MetaCap

Medical Properties Trust Inc. (MPT)

NYSE: MPTReal EstateReal Estate Investment TrustsUSD

1.75+0.11 (+6.71%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MPT stock chart

Technical analysis

Key statistics

All statistics
Dividend yield
20.57% ($0.36)
Ex-dividend date
Sep 10, 2026
52-week range
1.48 – 6.47
Day range
1.62 – 1.91
Volume / Avg
57.07M / 16.74M
Beta
—

52-week range

$1.48$6.47

MPT stock today

On Nov 20, MPT ended the session at $1.75, adding $0.11 (6.71%), versus the S&P 500's 3.70% decline. Volume was 3.4x the average at 57.07M shares, a sign of unusually heavy trading. Shares are 73.0% below their 52-week high of $6.47, set on Feb 19, 2026 and 18.2% above the 52-week low of $1.48, near the bottom of the past year's range.

MPT is down 65.0% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 67.0%. At 4.2x trailing earnings, Medical Properties trades below the peer-group median of 34.1x. Medical Properties pays an annual dividend of $0.36 per share, a 20.57% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Medical Properties

Company profile

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 365 facilities and approximately 37,000 licensed beds in nine countries and across three continents as of September 30, 2026.

Industry
Real Estate Investment Trusts
CEO
Mr. Larry H. Portal
Headquarters
Birmingham, AL
Employees
121

Financial highlights

Full financials

In fiscal 2025, Medical Properties generated $972.0 million in revenue, down 2.4% from fiscal 2024, its first annual decline since 2023. Medical Properties reported a net loss of $277.0 million, compared with a loss of $2.41 billion a year earlier. Gross margin was 90.7% (down from 92.6%).

Medical Properties annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$972.02M$995.55M$871.80M$1.54B$1.54B
Growth-2.36%+14.19%-43.49%-0.12%+23.65%
Net income$-277.05M$-2.41B$-556.48M$902.60M$656.02M
EPS (diluted)$-0.46$-4.02$-0.93$1.50$1.11

Analyst forecast

Forecast

Consensus (7 analysts)

hold

Avg. price target

$3.55+102.86%

  • Strong buy 2
  • Buy 0
  • Hold 3
  • Sell 0
  • Strong sell 2

Target range

Low $2.00High $5.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 29, 2026
EPS actual vs est.
$0.13 vs $0.13

Dividends

Dividend history
Annual dividend
$0.36
Last payment
$0.09
Ex-dividend date
Sep 10, 2026

MPT news

All MPT news

Medical Properties peers

Real Estate sector
MPT peer companies
CompanyPrice% ChgMarket capCompare
LADRLadder Capital Corp Class A8.21-1.08%$1.03Bvs MPT
DEAEasterly Government Properties Inc.21.29-0.93%$1.04Bvs MPT
PSTLPostal Realty Trust Inc. Class A22.54+0.94%$970.47Mvs MPT
BFSSaul Centers Inc.26.89-1.32%$937.01Mvs MPT
JBGSJBG SMITH Properties12.15+2.97%$926.28Mvs MPT
ALXAlexander's Inc.232.24-1.11%$1.19Bvs MPT
INNSummit Hotel Properties Inc.7.23+0.70%$873.83Mvs MPT
UMHUMH Properties Inc.13.92-1.97%$1.19Bvs MPT

Indexes, lists and sector

Medical Properties stock FAQ

What is Medical Properties's stock price today?

MPT last traded at $1.75 as of Nov 20, 4:00 PM EST, up 6.71% on the day. Prices are delayed at least 15 minutes.

Does Medical Properties pay a dividend?

Yes. Medical Properties pays $0.36 per share annually, a 20.57% yield. The most recent dividend of $0.09 had an ex-dividend date of Sep 10, 2026.

What is MPT's P/E ratio?

MPT trades at a trailing P/E ratio of 4.17, compared with a median of 34.1 for its closest peers.

Who is Medical Properties's CEO?

Mr. Larry H. Portal is the chief executive officer of Medical Properties Trust Inc., which has about 121 employees.

What is the MPT 52-week high?

The 52-week high for MPT is $6.47 and the 52-week low is $1.48. The stock is currently 73.0% below its high.

Compare MPT